- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Global Thrombectomy Devices Market Report Summary
The global thrombectomy devices market was valued at USD 1.37 billion in 2024, is estimated to reach USD 1.47 billion in 2025, and is projected to reach USD 2.60 billion by 2033, growing at a CAGR of 7.4% during the forecast period from 2025 to 2033.
The growth of the global thrombectomy devices market is driven by the rising incidence of cardiovascular diseases, increasing demand for minimally invasive procedures, and greater clinical preference for thrombectomy in treating acute vascular blockages. Growing awareness about the benefits of thrombectomy procedures, technological advancements in device design, and expanding applications across neurovascular, cardiovascular, and peripheral vascular conditions are further supporting market expansion. Moreover, the rise in the aging population and growing adoption of advanced interventional treatments are broadening the global demand for thrombectomy devices.
Key Market Trends
- Rising prevalence of cardiovascular diseases, stroke, and deep vein thrombosis is accelerating demand for thrombectomy procedures worldwide.
- Growing preference for minimally invasive and image-guided thrombectomy techniques due to improved recovery outcomes.
- Increasing adoption of mechanical thrombectomy devices, especially stent retrievers, driven by superior clinical efficacy in stroke management.
- Expanding technological innovation in aspiration systems, hydrodynamic devices, and ultrasonic thrombectomy platforms.
- Growth in hospital-based interventional procedures supported by improved reimbursement policies and skilled surgical infrastructure.
Segmental Insights
- Based on type, the mechanical thrombectomy devices segment was the largest and held a significant share of the global thrombectomy devices market in 2024. The segment’s dominance is attributed to the rising use of stent retrievers in stroke interventions, strong reimbursement support, and higher clinical success rates in clot removal.
- Based on application, the cardiovascular segment accounted for a major share of the market in 2024. Increasing incidence of heart attacks, peripheral arterial disease, and thrombus-related complications continues to fuel segment growth.
- The neurovascular application segment is gaining rapid momentum and is projected to grow at a promising CAGR due to increasing cases of ischemic stroke and rising preference for endovascular clot retrieval.
- Based on end user, hospital surgical centers were the largest segment in 2024 due to high procedural volume, advanced imaging infrastructure, and increasing adoption of minimally invasive thrombectomy procedures.
- Based on disease type, coronary diseases led the market in 2024, supported by rising awareness of early intervention and availability of advanced thrombectomy solutions in both developed and emerging countries.
Regional Insights
The global thrombectomy devices market is experiencing steady growth across major regions, driven by rising cardiovascular burden, expanding healthcare infrastructure, and increasing adoption of minimally invasive interventional techniques.
- North America was the largest contributor in 2024, supported by strong presence of key industry players, growing incidence of stroke and heart disease, and rapid uptake of advanced thrombectomy technologies. The U.S. remains the major driver, with high medical procedure volumes and favorable reimbursement systems.
- Europe is expected to remain the second-largest regional market, driven by increasing aging populations, rising prevalence of CVDs, and strong adoption of mechanical thrombectomy in leading countries such as Germany, France, and the U.K.
- Asia Pacific is the fastest-growing regional market, fueled by expanding healthcare access, rising cardiovascular disease cases, and increasing penetration of local manufacturers. India and China remain key contributors due to large patient populations and growing awareness of minimally invasive therapies.
- Latin America is witnessing steady growth, supported by rising geriatric population, growing burden of cardiovascular diseases, and increasing adoption of minimally invasive procedures.
- Middle East & Africa is projected to grow moderately due to increasing awareness and gradual improvement in healthcare systems, although device costs and shortage of skilled professionals remain challenges.
Competitive Landscape
The global thrombectomy devices market is dominated by leading medical device manufacturers with strong technological capabilities, extensive product portfolios, and global distribution networks. Companies are focusing on developing next-generation thrombectomy systems, expanding clinical research, and strengthening partnerships with hospitals and cardiac centers to enhance adoption. Competition is driven by innovation in mechanical, aspiration, and hydrodynamic thrombectomy technologies, alongside strategic mergers and acquisitions. Prominent players in the global thrombectomy devices market include Stryker Corporation, Medtronic Plc, Boston Scientific Corporation, Penumbra Inc., Johnson & Johnson, Terumo Corporation, Spectranetics Corporation, Edwards Lifesciences Corporation, Argon Medical Devices Inc., and Teleflex Incorporated.
Global Thrombectomy Devices Market Size
The global thrombectomy devices market size was valued at USD 1.37 billion in 2024. The size of the thrombectomy devices market is forecasted to be USD 2.60 billion by 2033 from USD 1.47 billion in 2025, growing at a CAGR of 7.4% during the forecast period.
Thrombectomy devices are used to remove clots from a blood vessel performed in an interventional procedure. It is generally used as a last resort as continuous blockage of blood flow to organs can lead to a situation known as necrosis. During a procedure, these devices will minimize the damage to the vessel wall. Thrombectomy devices can even be used to treat deep vein thrombosis, pulmonary embolism, neurovascular thrombosis conditions, and peripheral arterial, according to the size and diameter and depending on the affected area. Balloon embolectomy, aspiration embolectomy, and surgical embolectomy are the most used thrombectomy device procedures.
MARKET DRIVERS
The growing patient count suffering from CVDs is one of the major factors propelling the global thrombectomy devices market growth.
The usage of thrombectomy devices has increased with the growing population suffering from cardiovascular diseases. According to the data published by the Centers for Disease Prevention and Control (CDC), for every second, one person in the United States is getting a heart attack, and an estimated 805,000 heart attacks are being recorded in the United States every year. These devices help eliminate the blood clots from the blood vessels and can help restore the blood flow and prevent the complications of CVDs such as stroke and heart attack. Therefore, the increasing incidence of cardiovascular diseases worldwide is estimated to promote the demand for thrombectomy devices, as these conditions need immediate medical assistance to avoid serious health situations. In addition, rising awareness levels regarding the benefits associated with thrombectomy procedures and the growing adoption of minimally invasive surgeries are anticipated to result in the growth of the thrombectomy devices market.
The growing adoption of sedentary lifestyles and increasing demand for minimally invasive surgeries are accelerating the growth rate of the thrombectomy devices market.
The growing aging population is expected to contribute to the growing demand for thrombectomy devices in the coming years. The increase in the geriatric population leads to evolving various disease conditions, which must have surgical interventions for treatment. This promotes the demand levels for these devices and boosts the market’s growth rate. Moreover, increasing the target patient population is boosting the thrombectomy devices market. In addition, the rise in technological innovations in the medical field and the increasing prevalence of cardiovascular diseases are significant market growth opportunities. Moreover, the increase in research and development investments is boosting the thrombectomy devices market.
MARKET RESTRAINTS
The lack of skilled professionals is the major restrain to the thrombectomy devices market. In addition, the high cost associated with thrombectomy devices is hampering the global market. Moreover, the difficulty of using new equipment is constraining the thrombectomy devices market growth. In addition, the lack of awareness about peripheral vascular diseases in emerging countries is challenging market growth. Moreover, the side effects of using thrombectomy devices, such as bleeding from the catheter inserted and the presence of bruce in the area causing pain, are hindering the growth rate of the thrombectomy devices market.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| Segments Covered | By Type, Application, End-User, Disease, and Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | North America, Europe, APAC, Latin America, Middle East & Africa |
| Market Leader Profiled | Stryker Corporation (U.S.), Medtronic Plc (U.S.), Boston Scientific Corporation (U.S.), Penumbra, Inc. (U.S.) Johnson & Johnson (U.S.), Terumo Corporation (Japan), Spectranetics Corporation (U.S.), Edwards Lifesciences Corporation (U.S.), Argon Medical Devices, Inc. (U.S.), and Teleflex Incorporated (U.S.). |
SEGMENTAL ANALYSIS
By Type Insights
The mechanical thrombectomy devices segment is anticipated to account for the largest share of the global thrombectomy devices market in 2024. The dominance of the segment is expected to continue during the forecast period. The growing requirement for stent retrievers and supportive reimbursement policies are propelling the growth of the mechanical thrombectomy devices segment. Acandis and Sela Medical are some of the notable manufacturers of mechanical thrombectomy devices. Moreover, mechanical thrombectomy devices are more effective in reducing stroke-related disability and mortality. Therefore, the segment of stent retrievers is estimated to showcase promising growth during the forecast period.
By Application Insights
The cardiovascular segment had the major share of the global market in 2024. The growing incidence of CVDs worldwide is one of the major factors driving segmental growth. In addition, the benefits of mechanical thrombectomy in heart surgeries and the rise in minimally invasive cardiac surgeries propel the cardiovascular disease segment.
On the other hand, the neurovascular application segment is gaining attention and is anticipated to grow at a prominent CAGR during the forecast period.
By End User Insights
The hospital surgical centers segment dominated the market in 2024 and is estimated to hold a notable share of the global market during the forecast period owing to the growing number of people suffering from chronic vascular diseases and the rise in ultrasonic thrombectomy clinical applications.
By Diseases Insights
The coronary diseases segment led the market in 2024. The segment’s dominance is anticipated to continue throughout the forecast period owing to rising awareness among people over the availability of quality treatment procedures in developed and developing countries.
REGIONAL ANALYSIS
North America held the largest share of the global market in 2024, and the region’s dominance is expected to continue in the coming years. The presence of key market participants and increased adoption of technological developments in manufacturing thrombectomy devices propel the market growth in North America. In addition, the rising aging population and incidence of cardiovascular diseases are further fuelling the growth rate of the North American region. The major contributors to the North American market are the US and Canada. For instance, according to the CDC, Stroke is the fifth major cause of death in the United States, with 130,000 deaths yearly. Moreover, 800,000 people have a stroke every year. In addition, the increased incidence of cardiovascular diseases and technological advancements in the medical field propel the market. Furthermore, numerous vital players are boosting the thrombectomy devices market in North America.
The European market is expected to account for the second-largest market share in the world during the forecast period. During the forecast period, the European market is projected to grow at a healthy CAGR. The growing incidence of cardiovascular diseases and the increasing geriatric population contribute to the growth of the European thrombectomy devices market. Germany accounted for the largest share of the European region in 2023 and is estimated to continue dominating the European market in the coming years.
The Asia-Pacific region is the fastest-growing market globally. The presence of local manufacturers and growing distribution networks are accelerating the market growth in this region. India is a major contributor to the Asia-Pacific market. The rising adoption of thrombectomy devices and the rising patient count suffering from cardiovascular diseases support the thrombectomy devices market in the Asia-Pacific region. In addition, factors such as the large patient population and growing awareness among healthcare professionals regarding the advantages associated with using thrombectomy devices are favoring regional market growth.
Latin America is expected to grow steadily during the forecast period owing to the growing geriatric population, rising prevalence of cardiovascular diseases, growing adoption of a sedentary lifestyle, increasing demand for minimally invasive procedures, and technological innovations in the medical field. However, some of the restraints in this market are difficulty using new equipment, lack of skilled workers, and lack of awareness about peripheral vascular diseases.
The market in the Middle East & Africa is forecasted to grow at a sluggish growth rate and hold a moderate share of the global market in the coming years.
KEY MARKET PLAYERS
Companies playing a noteworthy role in the global thrombectomy devices market include
- Stryker Corporation (U.S.)
- Medtronic Plc (U.S.)
- Boston Scientific Corporation (U.S.)
- Penumbra, Inc. (U.S.)
- Johnson & Johnson (U.S.)
- Terumo Corporation (Japan)
- Spectranetics Corporation (U.S.)
- Edwards Lifesciences Corporation (U.S.)
- Argon Medical Devices, Inc. (U.S.)
- Teleflex Incorporated (U.S.)
MARKET SEGMENTATION
This research report on the global thrombectomy devices market has been segmented and sub-segmented based on type, application, end-user, disease, and region.
By Type
- Mechanical Thrombectomy Devices
- Stent Retrievers
- Basket/Brush Retrievers
- Coil Retrievers
- Ultrasonic Thrombectomy Devices
- Aspiration Thrombectomy Devices
- Hydrodynamic Thrombectomy Devices
By Application
- Peripheral Vascular Application
- Neurovascular Application
- Cardiovascular Application
By End User
- Research Laboratories & Academic Institutes
- Ambulatory Surgical Centers
- Hospital Surgical Centers
By Diseases
- Coronary diseases
- Neural diseases
- Peripheral diseases
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- The Middle East and Africa